Can a vaccine built for one Ebola virus stop another? The World Health Organization is about to find out
The World Health Organization (WHO) has recommended prioritizing the Ervebo vaccine for testing in a clinical trial in the Democratic Republic of the Congo. The vaccine was originally developed to protect against Zaire ebolavirus, the species responsible for the devastating West African epidemic just over a decade ago. It was not designed for the Bundibugyo species responsible for the current…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
